Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Saturated Fat: Red meat is higher in saturated fat than fish
Summary Semaglutide drives systemic fat loss rather than spot reduction, as shown in the SEMALEAN study, which reported a 15% reduction in total body fat mass
Tirzepatide# Tirzepatide is a 39-amino acid peptide with a C20 fatty diacid side chain that activates two receptors: GIP receptor : Tirzepatide shows approximately 5-fold selectivity for GIP over GLP-1 receptors, representing a GIP-dominant dual agonist GLP-1 receptor : Provides complementary glucose-lowering and appetite-suppressing effects The GIP receptor engagement is a key differentiator from pure GLP-1 agonists like semaglutide
Common adverse effects include nausea, vomiting, diarrhoea, abdominal pain, and decreased appetite, particularly during dose escalation
Most searches for segulatide are misspellings of semaglutide
